They are likely locked out as the annual report noted advanced discussions on Certus recurring revenue so generally they are unable to buy with market sensitive news in the pipeline, I think. Others may know more here. Also locked out maybe 2 weeks before 4C and annual and half year results. Agree however be good to see some Director buying at some stage. MC holds a decent whack though.
I think it feels like they are plodding along but reckon we will see a flurry of news in October. Certus release perhaps. Recurring revenue deal. Zoleo and Go! Orders squarely due. 4C.
BCC Price at posting:
26.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)